{
    "eid": "2-s2.0-85066762715",
    "title": "Gut Microbiota in Patients With Irritable Bowel Syndrome\u2014A Systematic Review",
    "cover-date": "2019-07-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Hepatology",
            "@code": "2721",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Gastroenterology",
            "@code": "2715",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Comparison",
        "Infection",
        "Inflammation",
        "Intestine"
    ],
    "authors": [
        "Rapat Pittayanon",
        "Jennifer T. Lau",
        "Yuhong Yuan",
        "Grigorios I. Leontiadis",
        "Frances Tse",
        "Michael Surette",
        "Paul Moayyedi"
    ],
    "citedby-count": 340,
    "ref-count": 50,
    "ref-list": [
        "Functional bowel disorders",
        "Survey of the AGA membership relating to patients with functional gastrointestinal disorders",
        "Costs of irritable bowel syndrome in the UK and US",
        "Burden of gastrointestinal, liver, and pancreatic diseases in the United States",
        "The irritable bowel syndrome: mechanisms and a practical approach to management",
        "Postinfectious irritable bowel syndrome\u2014a meta-analysis",
        "Postinfectious irritable bowel syndrome: follow-up of a patient cohort of confirmed cases of bacterial infection with Salmonella or Campylobacter",
        "Faecal microbiota composition and host-microbe cross-talk following gastroenteritis and in postinfectious irritable bowel syndrome",
        "Non-enteric infections, antibiotic use, and risk of development of functional gastrointestinal disorders",
        "Molecular analysis of the luminal- and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome",
        "Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome",
        "Functional dysbiosis within the gut microbiota of patients with constipated-irritable bowel syndrome",
        "Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome",
        "Structural alterations of faecal and mucosa-associated bacterial communities in irritable bowel syndrome",
        "Molecular analysis of faecal and duodenal samples reveals significantly higher prevalence and numbers of Pseudomonas aeruginosa in irritable bowel syndrome",
        "IBS-associated phylogenetic unbalances of the intestinal microbiota are not reverted by probiotic supplementation",
        "Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome",
        "Quantitative profiling of gut microbiota of children with diarrhea-predominant irritable bowel syndrome",
        "Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome",
        "Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome",
        "Differences of microbiota in small bowel and faeces between irritable bowel syndrome patients and healthy subjects",
        "Interplay between bile acid metabolism and microbiota in irritable bowel syndrome",
        "Molecular characterization of the intestinal microbiota in patients with and without abdominal bloating",
        "Involvement of shared mucosal-associated microbiota in the duodenum and rectum in diarrhea-predominant irritable bowel syndrome",
        "Similar fecal microbiota signatures in patients with diarrhea-predominant irritable bowel syndrome and patients with depression",
        "Reduction of butyrate- and methane-producing microorganisms in patients with irritable bowel syndrome",
        "The relationship between faecal-associated and mucosal-associated microbiota in irritable bowel syndrome patients and healthy subjects",
        "Fecal microbiota in patients with irritable bowel syndrome compared with healthy controls using real-time polymerase chain reaction: an evidence of dysbiosis",
        "Identification of an intestinal microbiota signature associated with severity of irritable bowel syndrome",
        "Distinct microbial populations exist in the mucosa-associated microbiota of diarrhea predominant irritable bowel syndrome and ulcerative colitis",
        "Diversity of the human intestinal microbial flora",
        "Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces",
        "Gastrointestinal microbiota in irritable bowel syndrome: their role in its pathogenesis and treatment",
        "A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes",
        "Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease",
        "Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach",
        "Degradation of organic acids by dairy lactic acid bacteria",
        "Richness of human gut microbiome correlates with metabolic markers",
        "Quantitative detection of enterotoxigenic Bacteroides fragilis subtypes isolated from children with and without diarrhea",
        "Colonization of mucin by human intestinal bacteria and establishment of biofilm communities in a two-stage continuous culture system",
        "Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics",
        "Faecalibacterium prausnitzii inhibits interleukin-17 to ameliorate colorectal colitis in rats",
        "Are there any different effects of Bifidobacterium, Lactobacillus and Streptococcus on intestinal sensation, barrier function and intestinal immunity in PI-IBS mouse model?",
        "Bifidobacteria and butyrate-producing colon bacteria: importance and strategies for their stimulation in the human gut",
        "Probiotic Bifidobacterium longum NCC3001 reduces depression scores and alters brain activity: a pilot study in patients with irritable bowel syndrome",
        "p-Hydroxyphenylacetate decarboxylase from Clostridium difficile. A novel glycyl radical enzyme catalysing the formation of p-cresol",
        "Structural insight of dopamine beta-hydroxylase, a drug target for complex traits, and functional significance of exonic single nucleotide polymorphisms",
        "Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome",
        "Experimental and analytical tools for studying the human microbiome",
        "Primer and platform effects on 16S rRNA tag sequencing"
    ],
    "affiliation": [
        {
            "affiliation-city": "Hamilton",
            "@id": "60108362",
            "affilname": "Farncombe Family Digestive Health Research Institute",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60108362",
            "affiliation-country": "Canada"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Canadian Institutes of Health Research"
    ]
}